Sabeel Solima M A, Salih Mohamed Ahmed, Ali Manasik, El-Zaki Salah-Eldin, Abuzeid Nadir, Elgadi Zeinab Abubaker Mohammed, Altayb Hisham N, Elegail Asrar M A, Ibrahim Nuha Y, Elamin Bahaeldin K
Department of Microbiology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan; Microbiology Department, Faculty of Medical Laboratory Sciences, Ibn Sina University, Khartoum, Sudan.
Department of Bioinformatics, Africa City of Technology, Khartoum, Sudan.
Tuberc Res Treat. 2017;2017:8340746. doi: 10.1155/2017/8340746. Epub 2017 Jan 18.
Currently, mutations in , , and genes and promoter were considered to be involved in conferring resistance to rifampicin, isoniazid, and streptomycin in (MTB). The aims of this study were to detect the prevalence of first-line tuberculosis (TB) drug resistance among a group of previously treated and newly detected TB patients, to determine the association between prevalence of multidrug resistance (MDR) and demographic information (age and sex), to explain genes correlated with MDR , and to characterize MTB via 16S ribosomal RNA (16S rRNA) analysis. A hundred MTB isolates from Sudanese pulmonary TB patients were included in the study. The proportional method of drug susceptibility test was carried out on Löwenstein-Jensen media. Multiplex PCR of and genes and promoter was conducted; then genes were amplified by conventional PCR and were sequenced. The sequences of the PCR product were compared with known gene sequences in the GenBank database by multiple sequence alignment tools. The prevalence of MDR was 14.7% among old cases and 5.3% among newly diagnosed cases. Mutations in could be considered as a diagnostic marker.
目前,人们认为、和基因以及启动子的突变与结核分枝杆菌(MTB)对利福平、异烟肼和链霉素的耐药性有关。本研究的目的是检测一组既往接受过治疗和新发现的结核病(TB)患者中一线结核病耐药性的流行情况,确定多药耐药(MDR)流行率与人口统计学信息(年龄和性别)之间的关联,解释与MDR相关的基因,并通过16S核糖体RNA(16S rRNA)分析对MTB进行特征描述。该研究纳入了100株来自苏丹肺结核患者的MTB分离株。在罗-琴培养基上进行药物敏感性试验的比例法。对和基因以及启动子进行多重聚合酶链反应(PCR);然后通过常规PCR扩增基因并进行测序。通过多重序列比对工具将PCR产物的序列与GenBank数据库中已知的基因序列进行比较。MDR在旧病例中的流行率为14.7%,在新诊断病例中的流行率为5.3%。基因中的突变可被视为一种诊断标志物。